Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus’ replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Scientists have uncovered a surprising viral shortcut that turns moving cells into delivery vehicles for infection. Instead ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
A drug once designed for dengue virus, then quietly abandoned by industry, is suddenly back in the spotlight, and it may be ...
Zika virus (ZIKV) is a mosquito-borne orthoflavivirus that can cause birth defects, including microcephaly, a condition in which head and brain size are significantly reduced at birth. The collective ...
The origin of life on Earth becomes even more fascinating and complex as we peer into the mysterious world of viruses. Said ...
New findings reveal the presence of replication-competent Oropouche virus in semen, posing fresh questions about sexual transmission risks and public health safety. Research Letter: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results